Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biosimilars
Pharma
Sandoz, Henlius agree to $322M deal for 3 biosimilars
Sandoz has collaborated with Henlius to gain commercialization rights to three biosimilars for $100.5M up front and $322M if milestones are reached.
Kevin Dunleavy
Aug 17, 2026 10:46am
Novo, Alvotech written up after FDA site inspections
Jul 17, 2026 10:56am
How biosimilar developers are embracing next phase of US market
Jul 6, 2026 10:03am
Sun Pharma snaps up women's health leader Organon for $11.75B
Apr 27, 2026 11:06am
Amneal ponies up $1.1B for biosimilars specialist Kashiv
Apr 22, 2026 11:32am
FDA's Makary shares policy requests with Congress
Apr 7, 2026 11:04am
